The Coronavirus pandemic has created unprecedented strain on medical resources at health care institutions around the world. At many institutions this has resulted in efforts to prioritize cases with an attempt to balance the acuity of medical needs with available resources. Here we provide a framework for institutions and governments to help adjudicate treatment allocations to patients with neuro-oncologic disease. Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology.